Biotechnology & Medical Research

Page 1

BioSpecifics Technologies Corp announces positive data from Phase 2a study of CCH for treatment of Cellulite

5:36pm EDT

BioSpecifics Technologies Corp:Says positive, statistically results from randomized, double-blind Phase 2a study of CCH for potential treatment of cellulite, or edematous fibrosclerotic panniculopathy.Results showed that all three doses of CCH used in the study, including low, medium and high dose, demonstrated improvement in appearance of cellulite as measured by trial endpoints of physician and patient-assessed improvements.CCH was well-tolerated by all dose groups with most adverse events being mild to moderate and primarily limited to local injection area.

OncoGenex Pharmaceuticals Inc announces update on phase 3 ENSPIRIT trial evaluating Custirsen in advanced non-small cell lung cancer

4:00pm EDT

OncoGenex Pharmaceuticals Inc:Says Phase 3 ENSPIRIT trial, evaluating custirsen in treatment of non-small cell lung cancer (NSCLC), is continuing as planned per recommendation of Independent Data Monitoring Committee (IDMC) based upon completion of first interim futility analysis.

Galena Biopharma appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

7:05am EDT

Galena Biopharma Inc:Appoints Mark W. Schwartz, Ph.D as President and Chief Executive Officer, effective immediately.Replaces Mark J. Ahn, Ph.D. who has resigned as the President and CEO and as a director.

NanoRepro AG confirms FY 2014 revenue outlook

2:48am EDT

NanoRepro AG:Says confirms FY 2014 revenue targets.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.